Insertional Mutagenesis Identifies a STAT3/Arid1b/β-catenin Pathway Driving Neurofibroma Initiation

Area of Science:

• Oncology
• Genetics
• Molecular Biology

Background:

• Neurofibromatosis type 1 (NF1) is a genetic disorder characterized by the development of neurofibromas.
• The precise molecular mechanisms initiating NF1-associated neurofibromas remain incompletely understood.

Purpose of the Study:

• To identify the genes and signaling pathways responsible for the initiation of NF1 neurofibromas.
• To elucidate the molecular interactions within the identified pathway.

Main Methods:

• Unbiased insertional mutagenesis screening in mouse models.
• Genetic deletion of specific genes (Stat3) in Schwann cell progenitors (SCPs) and Schwann cells (SCs).
• Molecular analyses including gene expression, protein activity assays, and epigenetic modification studies.

Main Results:

• A novel Nf1-Stat3-Arid1b/β-catenin pathway was identified as crucial for NF1 neurofibroma initiation.
• Genetic deletion of Stat3 in SCPs and SCs inhibited neurofibroma formation by reducing SCP self-renewal and β-catenin activity.
• P-STAT3 and β-catenin expression positively correlated in human NF1 neurofibromas, suggesting conserved pathway activity.
• Mechanistically, P-Stat3 represses Gsk3β and Arid1b, leading to increased β-catenin levels, with Stat3-mediated repression of Arid1b involving epigenetic modifications.

Conclusions:

• The study maps a critical neural tumorigenesis pathway initiated by Nf1 loss.
• The findings highlight the roles of Stat3, Arid1b, and β-catenin in NF1 pathogenesis.
• Targeting the JAK/STAT and Wnt/β-catenin pathways presents a potential therapeutic strategy for NF1 neurofibromas.